Update on Postoperative Cognitive Dysfunction

Published on 06/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1971 times

Advances in Anesthesia, Vol. 28, No. 1, 2010

ISSN: 0737-6146

doi: 10.1016/j.aan.2010.09.003

An Update on Postoperative Cognitive Dysfunction

Postoperative cognitive dysfunction or decline (POCD) is increasingly recognized as a common phenomenon after major surgery [14]. Because older age is a strong preoperative risk factor of POCD [2,5], the incidence of POCD is expected to increase as the population of older surgical patients grows. Improving the measurement of POCD and identifying its etiology is clinically important, as recent studies have associated POCD with impairments in daily functioning [6], premature departure from the labor market [7], and dependency on government economic assistance after hospital discharge [7].

In this article, we review the definitions of POCD and discuss current methodological issues in this growing area of research. We also present relevant hypotheses on its pathophysiology and discuss the long-term significance of POCD.

Broadly speaking, POCD refers to problems in thinking and memory after surgery. POCD is not yet recognized in the International Classification of Diseases and is not listed as a diagnosis in the Diagnostic and Statistical Manual [8]. The term POCD is used mostly in literature to represent a decline in a variety of neuropsychological domains including memory, executive functioning, and speed of processing. POCD has been defined in a consensus statement as “a spectrum of postoperative central nervous system (CNS) dysfunction both acute and persistent … including brain death, stroke, subtle neurologic signs and neuropsychological impairment [9]. ”

POCD should be distinguished from delirium or dementia. Delirium describes an acute confusional state featuring disturbances in attention and decreased awareness of the environment [10,11]. Delirium symptoms fluctuate during the course of the day, and the patient often is disoriented. In addition, hallucinations and inappropriate communication or behavior may be observed in the presence of delirium. In contrast, a typical patient with POCD is oriented but exhibits significant declines from his or her own baseline level of performance on one or more neuropsychological domains [1215]. After surgery, changes in cognitive status may present in the form of a frank delirium or POCD, or both. POCD differs from dementia, which describes a chronic, often insidious, decline in cognitive function. Alzheimer’s disease remains the most common form of dementia, but there is considerable overlap in neurodegenerative disease.

Selection of neurocognitive tests to measure POCD

Most studies of POCD have focused on describing changes in brain functioning, and more specifically, have studied either performance-based or self-report perceptions of changes in memory, executive function, attention, learning, language, visual spatial skills, mathematics, motor function, and anxiety or depression [16]. The selection of neurocognitive tests to document these cognitive changes varies extensively between studies [16]. This variability in choice of tests may be because of the absence of a clear, theoretically derived, and empirically tested model that describes the causes and outcomes of cognitive changes associated with the surgical experience. Therefore, while a consensus-recommended battery of tests was established more than 10 years ago [9], it was not accompanied by this necessary model [17], nor did it have an explanation of how the tests within the battery met the consensus definition of POCD. Without the adoption of such a model, it is difficult to conclude whether tools intended to detect POCD are, in fact, assessing the presence of POCD.

Since the consensus guidelines were published in 1995, diagnostic criteria for POCD have been suggested. One stated criterion specified that there must be significant changes in neuropsychological tests involving several of the following domains: learning and memory, attention, executive functioning, and language [18]. Additional areas for assessment suggested by Deiner and Silverstein include declines in perception and abstract thinking [19]. Although these guidelines provide guidance for the selection of tools to assess for POCD, they were not accompanied with specific justification for the choice of cognitive domains that should be assessed when testing a patient for POCD [17].

Recent reviews of POCD after cardiac [16] and noncardiac [20] surgery reveal that the 2 most commonly assessed cognitive domains assessed were (1) learning and memory and (2) attention and concentration. Of the studies included in these reviews, 97% of studies including patients undergoing cardiac surgery included a memory and learning test and 70% of studies including patients undergoing noncardiac surgery included a memory and learning test. Similarly, 94% of studies including patients undergoing cardiac surgery included an attention and concentration test and 57% of studies including patients undergoing noncardiac surgery included an attention and concentration test. About one-third of studies included tests of verbal and language skills and tests of visual and spatial skills. Still fewer studies included tests of numerical reasoning (6% for both types of surgical subjects) or executive function (14% for cardiac surgery and 6% for noncardiac surgery subjects). Few studies reported the percentage of subjects who experienced significant decline in performance after surgery for each cognitive test. Consequently, it is difficult to determine whether patterns of deficits in specific domains emerge across studies. One review concluded that declines in memory and attention and psychomotor function were consistently found after coronary artery bypass graft (CABG), but cautioned that the domains of POCD detected are likely to be a function of the tests used to assess POCD [21]. Increased reporting of results for individual tests would help inform the development of a conceptual framework that explains which domains of cognitive functioning are expected to be affected by different surgical experiences.

Many studies have used composite measures of cognitive functioning to assess patients for the presence of POCD. Nearly a third of studies of POCD in patients undergoing noncardiac surgery incorporated composite measures of functioning in their protocol [20]. The most commonly used composite measure was the Mini Mental State Examination (MMSE); it was included in 21% of reviewed studies. An important debate is whether composite measures and composite scores should be used to detect POCD. Composite measures and composite scores do not differentiate which areas of neuropsychological functioning are affected by the surgical experience. Understanding the specific areas of neuropsychological functioning involved in POCD would not only advance conceptual models of POCD, but would also help in specifying which self-care activities are likely to be affected by POCD. In contrast, Rasmussen and colleagues [22] suggest that the use of composite tests or scores is not problematic because the purpose of the postoperative neuropsychological testing is to detect the presence of general, rather than specific, changes in cognitive functioning.

Administration of neuropsychological tests

There are many procedural issues that should be considered when administering a neuropsychological protocol for the purpose of detecting POCD [22,23]. Those issues might be categorized into the following: test selection, test administration, and test scoring for the purpose of detection of POCD. Test selection should be guided by choosing tests that have validity for detecting change in functioning in those domains expected to be negatively affected by the surgical experience. In addition, there are several practical issues that should be considered when choosing tests for the assessment of POCD. For example, it is important to choose tests with difficulty levels that do not result in floor effects (many subjects scoring the lowest score possible) or ceiling effects (many subjects scoring the highest score possible) [23]. Tests that do not have floor or ceiling effects are likely to have greater sensitivity to detecting a change in functioning associated with surgery. Choosing tests with parallel versions reduces potential practice effects from remembering test stimuli from earlier administrations. This is particularly problematic for word-list learning tasks because some subjects are able to recall words from a prior administration of the task. The parallel versions should be administered in a different order between subjects (eg, ordered according to a Latin-square design) to avoid potential bias in estimates of change due to differential difficulty levels of different forms [24]. Tests should be validated for the language in which they will be administered. For example, the difficulty of word-list generation tasks that require the subject to list as many words as possible that begin with a specific letter varies depending on the letter specified [25]. Difficulty levels will vary across languages for the same letter.

Administration of tests used to detect POCD should be standardized across occasions and subjects. Consensus recommendations include that testing be conducted by “the same suitably qualified and trained individual and that the tests minimize subjectivity and be performed in a standardized manner” [9]. This recommendation is meant to reduce variance in subjects’ tests scores that cannot be ascribed to the subjects’ ability alone. Because preoperative performance may be negatively affected by surgery-associated anxiety [23], it has been suggested that the administration of mood and anxiety scales with the neuropsychological tests would allow for statistical adjustment of cognitive test scores by subjects’ mood state [22].

Although a variety of scoring methods for the detection of POCD have been used across studies, investigators generally agree that scoring methods should consider (1) baseline performance, (2) practice effects, and (3) change on more than one neuropsychological test [9,17,23,26]. Baseline assessments allow determination of whether an actual change in cognitive functioning occurred subsequent to the surgical event. Nearly half of studies of POCD have been conducted in adults undergoing cardiac surgery, a population at risk for cognitive changes because of underlying heart or vessel disease [27]. Practice effects refer to improvement in performance because of familiarity with test procedures and can occur in patients with [28] and without existing cognitive impairment [29]. A common way of measuring practice effects is to measure the average improvement in performance for a group of matched controls. An important question is how well the matched controls truly match the surgical population to which they are compared. For example, studies that provide comparisons between subjects and controls reveal that controls differ from subjects, with fewer males [5,30], lower depression levels [5], lower rates of comorbidity [31], and lower attrition rates in the control group [30].

Timing of assessment for POCD

Another methodology issue in the study of POCD is that no general consensus has been established thus far regarding the optimum timing of assessments after surgery. In previous studies, cognitive function was measured beginning 1 day to as long as 5 years after surgery. POCD can be broadly divided into acute, intermediate, and late or long-term changes based on information from previous studies. Specifically, acute POCD has been used to describe cognitive decline detected within 1 week after surgery, intermediate POCD for changes within 3 months, and long-term POCD for changes 1 to 2 years following surgery. However, the exact significance of detecting POCD at these various time points is unclear. The time interval at which a diagnosis of POCD holds the greatest clinical significance has not been determined, nor have any studies invalidated the importance of conducting assessments at a specific time point.

Early assessments of POCD likely capture a different phenomenon than what late assessments of POCD capture, and each are accompanied by a unique set of issues. Surgery-related factors may affect test performance in the immediate postoperative period, including acute pain [32,34], the use of drugs [24,35], nausea, limited mobility, and fatigue. Thus, it has been argued that patients should not be evaluated for POCD until at least 1 week postoperatively [9,14,36]. Recent evidence suggested this delay might be arbitrary, as negative outcomes are associated with POCD detected in the first week after surgery. In a 2008 study of patients undergoing noncardiac surgery, POCD detected at hospital discharge (mean duration of stay, <7 days) was associated with an increased risk of death within the first 3 months after surgery [5]. Restricting testing to only the later postoperative period is also problematic because many patients are already discharged within 1 week after surgery. In fact, recent data from the National Center for Health Statistics showed that the average lengths of stay for patients between the ages of 45 and 84 years are currently between 5.0 and 5.6 days [37]. It has been reported that the average length of stay of patients older than 50 years who underwent major noncardiac surgery with no postoperative complications was 4 days [38]. In our study, 88% of those identified with POCD were discharged within a week of surgery [34]. In addition, Rohan and colleagues [39] reported that 47% of patients undergoing minor noncardiac surgery were found to have POCD before discharge. These findings suggest that limiting screening for POCD to 7 days after surgery could result in missed recognition of POCD in many surgical patients. In-hospital patient education usually includes detailed instructions for wound care, administration of new medications, symptom monitoring, and details of needed restrictions in daily activities. If postsurgical patients are experiencing POCD at the time they are given self-care discharge instructions, their ability to understand and recall these instructions may be limited and may put them at risk for postsurgical complications.

The rate of patient attrition is noted to be lower in studies assessing for early rather than late POCD. Newman and colleagues [20] reported a 5.4% attrition rate for evaluations performed between 7 and 21 days after noncardiac surgery; 19% for evaluations between 22 days and 132 days; and 17% for evaluations beyond 6 months postoperatively. Patient attrition may be selective. In cohort studies, patients unavailable for follow-up were more likely to be older patients who had worse baseline cognitive performance [40] or were sicker [41]. If patients experiencing cognitive decline are more likely to decline assessment, this selective attrition will bias study results toward the null, obscuring the detection of cognitive changes postoperatively.

POCD assessments that occur in the immediate postoperative period are important for elucidating the relationship between POCD and delirium. Because POCD and delirium both feature deficits in attention, whether they are related events on a continuum or distinct conditions remains unclear. In a retrospective analysis of the International Study for Postoperative Cognitive Dysfunction (ISPOCD) research data, patients with postoperative delirium had a higher incidence of POCD 1 week postoperatively [40]. The ISPOCD study was not initially designed to measure postoperative delirium as a primary outcome, so validated measures of delirium were not incorporated into the study protocol. It is not clear whether detection of delirium via chart reviews and the Mini Mental State Examination (MMSE) performance has similar sensitivity and specificity for detecting delirium as that of commonly used measures such as the Confusion Assessment Methods (CAM) [11]. Although the ISPOCD results seem to suggest that postoperative delirium and POCD appear to be discrete events, other research provides support to the continuum hypothesis, specifically, that POCD is a subclinical from of delirium. For example, Monk and colleagues [5] found that patients who were delirious after major noncardiac surgery were also more likely to have POCD at hospital discharge. Furthermore, areas of cognitive functioning that show decline in patients with POCD such as attention are common with criteria for detecting delirium. In a study of older orthopedic patients, Lowery and colleagues [42] identified a group of patients with “subsyndrome delirium,” defined as those not meeting the CAM criteria for delirium but showing a decline in global cognitive functioning as measured by the MMSE. These patients exhibited greater declines in performance on attention tasks than did nondelirious patients within the first week after surgery. Because most cases of delirium occur in the early postoperative period, an improved understanding of the relationship between POCD and delirium will be derived from additional studies that perform neurocognitive testing and delirium assessment simultaneously within the first several days after surgery.

Pathophysiology of POCD

The exact pathophysiology of POCD remains undefined. Previous studies of POCD have focused on investigating the risk factors associated with early POCD. Table 1 describes the variables that have been shown to be associated with early/intermediate POCD. In terms of patient-related baseline factors, or sometimes called predisposing factors, increasing age and lower levels of education have been identified as the main ones in the early study by the International Study on Postoperative Dysfunction (ISPOCD) [2]. In a subsequent study by Johnson and colleagues [3] that included only a subset of the population reported in the initial study, the avoidance of alcohol intake was determined to be a predisposing factor for POCD. A patient’s preoperative cognitive status also has been shown to be associated with POCD [43].

Table 1 Patient-related risk factors for early/intermediate POCD

Patient-related risk factors Supporting evidence
Age ISPOCD, Stockton, Ancelin, Monk [2,5,92,96]
Education ISPOCD, Monk [2,5]
Burden of illness Monk [5]
Preoperative depression Leung (delirium only) [97]
Preoperative cognitive impairment Johnson [3]
Preoperative habits and drug use Monk [5]
Apolipoprotein E4 Heyer, Lelis, Leung, Tardiff [5860,62]

Proposed patient-related risk factors of POCD and studies with supporting evidence.

Abbreviations: ISPOCD, International Study on Post-Operative Cognitive Dysfunction; POCD, postoperative cognitive dysfunction or decline.

Whether patients have a genetic predisposition for development of the POCD genotype is not well understood because findings from studies to date are conflicting. Genetic studies from population-based investigations [44,45] have demonstrated a relationship between certain genotypes and the risk of dementia and cognitive decline. Specifically, elevated risk of Alzheimer’s disease has been demonstrated among individuals with the E4 allele of the apolipoprotein E (APOE) gene in many populations [46,47]. The E4 allele of APOE is associated with earlier onset of Alzheimer’s disease [48]; however, the APOE4 genotype is neither necessary nor sufficient for the occurrence of Alzheimer’s disease [48]. The APOE polymorphism also affects response to trauma, age-related cognitive decline, [49] and several other disorders [50,52]. APOE is a polymorphic protein associated with plasma lipoproteins. Three major isoforms can be recognized, designated as APOE2, APOE3, and APOE4, according to their relative position after isoelectric focusing [53]. APOE is unique among apolipoproteins in that it has a special relevance to nervous tissue [54]. APOE is involved in the mobilization and redistribution of cholesterol in repair, growth, and maintenance of myelin and neuronal membranes during development or after injury [55,57]. The 3 smaller studies that demonstrated an association between the APOE allele and cognitive decline were conducted in patients undergoing carotid endarterectomy and cardiac operations [58,60]. The largest study that failed to demonstrate an association between apolipoprotein E genotype and POCD measured at 1 week or 3 months after surgery was conducted in patients undergoing noncardiac surgery [61]. However, this study likely underestimated the incidence of POCD because the investigators considered any patients who were not “fit enough for testing” as not having POCD. Recently, McDonagh and colleagues [43] conducted a study in 394 older patients undergoing noncardiac surgery and similarly reported that apolipoprotein E4 was not associated with POCD measured at 6 weeks or at 1 year after surgery. Similarly, other biomarkers such as B-type natriuretic peptide, C-reactive protein, D-dimer, matrix mettaloproteinase-9, neuron-specific enolase, and S-100b also had no association with POCD measured at 6 weeks or at 1 year after surgery. The results on apolipoprotein E4 are in contrast to our work in 190 older patients undergoing noncardiac surgery, in which the presence of 1 copy of the E4 allele was associated with an increased risk of early postoperative delirium [62]. Even after adjusting for covariates, patients with 1 copy of the E4 allele were still more likely to have an increased risk of early postoperative delirium compared with those without the E4 allele. In contrast to the studies by Abildstrom and colleagues [61] and by McDonagh and colleagues [43], we measured delirium in the first few days after surgery, whereas the other investigators measured POCD at 6 weeks after surgery. One small study in critically ill patients corroborated our findings that apolipoprotein E4 was associated with a longer duration of delirium [63]. Methodological differences between delirium and cognitive assessments, difference in the timing of assessments, and potential differences in patient populations among different studies may result in differences in the findings. Nevertheless, the possible link between postoperative delirium and genetic predisposition is intriguing.

What is the possible mechanism between apolipoprotein and postoperative delirium? Previous studies suggest that the effects of APOE are mediated through alterations in lipid transport in regenerating neurons, proinflammatory cytokine release from activated microglia, amyloid precursor protein metabolism, increased blood brain carrier permeability, alterations in platelet function, and systemic inflammation [64,66]. One hypothesized mechanism is that APOE E4 allele diminishes the capacity for repair in cases of cerebral injury or capacity for homeostasis/maintenance. Whether this mechanism occurs to increase the likelihood of developing postoperative delirium remains to be proven.

In addition to predisposing risk factors, numerous potential precipitating risk factors for POCD have been investigated (Table 2). The early ISPOCD study reported that the duration of anesthesia, a second operation, postoperative infections, and pulmonary complications [2] increase the risk of POCD. In cardiac surgery, the use of cardiopulmonary bypass has been implicated as one of the precipitating factors [67,68]. During cardiopulmonary bypass, cannulation of the aortic root may result in cerebral microemboli, which could lead to POCD [69]. In addition, a profound systemic inflammatory response occurs with cardiopulmonary bypass, which may contribute to POCD [70]. However, despite the earlier reports that POCD is prevalent after cardiac surgery [67,68], studies in patients who underwent cardiac surgery without the use of cardiopulmonary bypass did not demonstrate a lower incidence of POCD, despite a smaller embolic load in the middle cerebral artery measured by Doppler in patients undergoing off-pump surgery [71,72]. Thus, it remains inconclusive how surgery type actually affects POCD. Similarly, whether the type of anesthesia affects POCD remains inconclusive. In experimental settings involving animals, general anesthetics produced neurotoxicity and subsequent cognitive impairment in young and aged animals, but whether these changes are reproducible in clinical studies has not been determined [73]. Most previous studies compared the cognitive outcomes between general versus regional anesthesia. Earlier studies suggested an association between general anesthesia and a higher incidence of cognitive dysfunction relative to epidural anesthesia [74,75]. However, recent studies concluded that there was no relationship between anesthetic techniques and the magnitude or pattern of postoperative cognitive dysfunction [1,2,4,76].

Table 2 Precipitating factors for early/intermediate POCD

Precipitating factors Supporting evidence Refuting evidence
Second operation ISPOCD [2] Monk [5]
Postoperative infection ISPOCD [2] Monk [5]
Respiratory complications ISPOCD [2] Monk [5]
General anesthetic ? ISPOCD, Williams-Russo [4,77]
Anesthetic type ? Leung [98]
Anesthetic maintenance (hypotension) ? Williams-Russo [1]
Pain management Leung, Vaurio [99,100] ?

Proposed precipitating factors for early or intermediate POCD and studies with supporting or refuting evidence.

Abbreviations: ISPOCD, International Study on Post-Operative Cognitive Dysfunction; POCD, postoperative cognitive dysfunction or decline.

If anesthesia type did not seem to affect POCD, what about the conduct of anesthesia? The influence of intraoperative hypotension on POCD has also been evaluated. In a prospective, randomized study of older adults (age >50 years) undergoing total hip replacement, Williams-Russo and colleagues [77] demonstrated that patients who underwent epidural anesthesia and were rendered markedly hypotensive had a similar incidence of postoperative cognitive dysfunction as those who were maintained in the normotensive state. Taken together, to date, no single anesthetic type or technique has been identified to be superior in minimizing POCD for older surgical patients.

Given that the type of surgery and anesthetic type and management do not appear to influence rates of POCD, our group has focused on events in the postoperative period that may influence POCD, given that patients experience substantial pain postoperatively and are administered many medications with central nervous system effects. In 225 patients 65 years or older undergoing noncardiac surgery, we measured POCD in the first 2 postoperative days [34]. In patients without postoperative delirium, 13% of patients experienced POCD on day 1, 7% on day 2, and 15% had POCD on either day 1 or day 2 after the surgery. Multivariate regression analyses revealed that only postoperative analgesia was associated with the development of POCD. Compared with those receiving postoperative analgesia through a patient-controlled analgesia device that administered opioids intravenously, those who received postoperative analgesia orally were at significantly lower risk for the development of POCD. Our results demonstrate that older patients undergoing noncardiac surgery who are not delirious can experience significant declines in cognitive functioning postoperatively. Those at least risk of experiencing POCD were those who received postoperative analgesia orally. Opioid analgesics administered orally may result in a lower blood level of the drug because of first-pass effect when compared with intravenously administered narcotics, which may directly cross the blood brain barrier. Alternatively, the use of oral narcotics for postoperative analgesia may be a marker for a less painful state. However, this result remains significant even when adjusting for the level of pain.

In addition to studies targeting the identification of risk factors of POCD, recent investigations have focused on identifying the pathophysiology for POCD. Surgery can result in a complex systemic response, which includes neuroinflammation [78]. Systemic and neural inflammation, which occur as a result of surgery, may directly affect patient outcome. For example, blood loss and tissue injury in orthopedic procedures might affect the immune system to produce an inflammatory response [79]. Data from preclinical studies support the concept that inflammation is a possible pathogenic mechanism for POCD, and cytokines such as interluekin-1β have been implicated [80,82]; however, the clinical relevance of these experimental findings remains to be determined. Future studies using translational and multidisciplinary approaches are indicated to determine the role of inflammation as a possible causative factor in the pathophysiology of POCD.

Finally, cognitive reserve and a patient’s propensity for developing adverse postoperative neurologic outcomes need to be considered when discussing the pathophysiology of POCD. A hypothetical construct coined “cognitive reserve” has been used to describe models of cognitive aging and situations where the brain sustains injury [83]. Surrogates of cognitive reserve have included education level, occupational attainment, and performance on tests of knowledge (such as vocabulary). Evidence that greater educational attainment is associated with a reduced relative risk of developing Alzheimer’s disease has been demonstrated in many previous studies [84,86]. The association between lower occupational attainment and incident dementia has been found in a number of studies as well [87]. Although cognitive reserve is typically invoked as an important concept in dementia research, there is also evidence that cognitive reserve may play a protective role against POCD. As a result, future research targeting the role of cognitive reserve in POCD and postoperative delirium is an intriguing idea and should be pursued.

Long-term significance of POCD

The question of whether major surgery and anesthesia ultimately lead to long-term cognitive decline is controversial. In a population study, Dijkstra and colleagues [88] reported that the number of operations and the total duration of anesthesia were related to the number of subject health-related complaints but did not predict cognitive performance or memory complaints. Several other studies that included assessments more than 6 months after surgery similarly reported no decline in cognitive status from that measured before surgery [8993]. However, 2 recent studies that included patients who had undergone noncardiac surgery reported that acute POCD was associated with increased mortality after surgery (for one study, at 1 year; and for the second study, at 3 months) [5,7]. Also, in cardiac surgical patients, Newman and colleagues [94] provided data showing that cognitive function at discharge was a significant predictor of long-term cognitive function. In contrast, a recent study by Avidan and colleagues [95] provides results to the contrary. In this study, the investigators enrolled participants from an Alzheimer’s disease research center who had substantial pre-event data. The subjects were stratified into 3 groups based on whether they underwent surgery, were admitted to a hospital for a major illness not requiring surgery, or did not undergo surgery and had no major illness (control group). Subjects were assessed annually, and some were assessed for as many as 21 years. The battery of neuropsychological tests administered at each occasion was comprehensive of those domains of cognitive function known to be affected in the presence of drugs and other precipitating events. The sophisticated statistical methods used in this study allowed assessments of subjects’ trajectory of cognitive performance before and after the event of interest. The study findings suggested that neither nondemented nor mildly demented individuals had accelerated long-term decline in cognitive function attributable to surgery or major illness compared with matched controls. Clearly, whether early POCD is related to accelerated long-term decline in cognitive function was not completely addressed by this study because cognitive assessments were not synchronized with hospitalization. Therefore, a definitive study to address the prognostic significance of cognitive dysfunction associated with surgery and/or hospitalization needs to include sufficient sample size and both short-term and long-term longitudinal assessments to more fully understand how major illness and surgery impacts quality of life and cognitive functioning, and to determine ultimately if there are reversible precipitating factors that are modifiable. Continuing research on POCD may also shed light about the pathophysiology of other neurodegenerative disease including Alzheimer’s disease.

References

[1] P. Williams-Russo, N. Sharrock, S. Mattis, et al. Cognitive effects after epidural vs general anesthesia in older adults. JAMA. 1995;274:44-50.

[2] J. Moller, P. Cluitmans, L. Rasmussen, et al. ISPOCD investigators: long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study. Lancet. 1998;351:857-861.

[3] T. Johnson, T. Monk, L.S. Rasmussen, et al. Postoperative cognitive dysfunction in middle-aged patients. Anesthesiology. 2002;96:1351-1357.

[4] L.S. Rasmussen, T. Johnson, H.M. Kuipers, et al. Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand. 2003;47:260-266.

[5] T.G. Monk, B.C. Weldon, C.W. Garvan, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008;108:18-30.

[6] B. Phillips-Bute, J.P. Mathew, J.A. Blumenthal, et al. Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med. 2006;68:369-375.

[7] J. Steinmetz, K.B. Christensen, T. Lund, et al. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology. 2009;110:548-555.

[8] American Psychiatric Association. American Psychiatric Association, Task Force on DSM-IV: diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th edition. Washington, DC, American Psychiatric Association, 2000.

[9] J. Murkin, S. Newman, D. Stump, et al. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg. 1995;59:1289-1295.

[10] Z. Lipowski. Delirium (acute confusional states). JAMA. 1987;258:1789-1792.

[11] S. Inouye, C. vanDyck, C. Alessi, et al. Clarifying confusion: the confusion assessment method. Ann Intern Med. 1990;113:941-948.

[12] J. Blumenthal, E. Mahanna, D. Madden, et al. Methodological issues in the assessment of neuropsychologic function after cardiac surgery. Ann Thorac Surg. 1995;59:1345-1350.

[13] G. Makensen, A. Gelb. Postoperative cognitive deficits: more questions than answers. Eur J Anaesthesiol. 2004;21:85-88.

[14] C.D. Hanning. Postoperative cognitive dysfunction. Br J Anaesth. 2005;95:82-87.

[15] C. Wu, W. Hsu, J. Richman, et al. Postoperative cognitive function as an outcome of regional anesthesia and analgesia. Reg Anesth Pain Med. 2004;29:257-268.

[16] J. Rudolph, K. Schreiber, D. Culley, et al. Measurement of post-operative cognitive dysfunction after cardiac surgery: a systematic review. Acta Anaesthesiol Scand. 2010;54:663-677.

[17] M. Lewis, P. Maruff, B. Silbert. Statistical and conceptual issues in defining post-operative cognitive dysfunction. Neurosci Biobehav Rev. 2004;28:433-440.

[18] A. Bekker, E. Weeks. Cognitive function after anaesthesia in the elderly. Best Pract Res Clin Anaesthesiol. 2003;17:259-273.

[19] S. Deiner, J.H. Silverstein. Postoperative delirium and cognitive dysfunction. Br J Anaesth. 2009;103(Suppl 1):i41-i46.

[20] S. Newman, J. Stygall, S. Hirani, et al. Postoperative cognitive dysfunction after noncardiac surgery. Anesthesiology. 2007;106:572-590.

[21] E. Symes, P. Maruff, A. Ajani, et al. Issues associated with the identification of cognitive change following coronary artery bypass grafting. Aust N Z J Psychiatry. 2000;34:770-784.

[22] L. Rasmussen, K. Larsen, P. Houx, et al. The assessment of postoperative cognitive function. Acta Anaesthesiol Scand. 2001;45:275-289.

[23] K. Funder, J. Steinmetz, L. Rasmussen. Methodological issues of postoperative cognitive dysfunction research. Semin Cardiothorac Vasc Anesth. 2010;14:119-122.

[24] L. Sands, I. Katz, S. Doyle. Detecting subclinical change in cognitive functioning in older adults. Part I: Explication of the method. Am J Geriatr Psychiatry. 1993;1:1-13.

[25] J. Borkowski, A. Benton, O. Spreen. Word fluency and brain damage. Neuropsychologia. 1967;5:135-140.

[26] A.M. Sauer, C. Kalkman, D. van Dijk. Postoperative cognitive decline. J Anesth. 2009;23:256-259.

[27] S.B. Rafnsson, I.J. Deary, F.B. Smith, et al. Cardiovascular diseases and decline in cognitive function in an elderly community population: the Edinburgh Artery Study. Psychosom Med. 2007;69:425-434.

[28] L.P. Sands, A. Phinney, I.R. Katz. Monitoring Alzheimer’s patients for acute changes in cognitive functioning. Am J Geriatr Psychiatry. 2000;8:47-56.

[29] L. Sands, I. Katz, S. Doyle. Detecting subclinical change in cognitive functioning in older adults: part 2 initial validation of the method. Am J Geriatr Psychiatry. 1993;1:275-287.

[30] A.M. Keizer, R. Hijman, C.J. Kalkman, et al. The incidence of cognitive decline after (not) undergoing coronary artery bypass grafting: the impact of a controlled definition. Acta Anaesthesiol Scand. 2005;49:1232-1235.

[31] B.S. Silbert, P. Maruff, L.A. Evered, et al. Detection of cognitive decline after coronary surgery: a comparison of computerized and conventional tests. Br J Anaesth. 2004;92:814-820.

[32] W. Duggleby, J. Lander. Cognitive status and postoperative pain: older adults. J Pain Symptom Manage. 1994;9:19-27.

[33] E. Heyer, R. Sharma, C. Winfree, et al. Severe pain confounds neuropsychological test performance. J Clin Exp Neuropsychol. 2000;22:633-639.

[34] Y. Wang, L. Sands, L. Vaurio, et al. The effects of postoperative pain and its management on postoperative cognitive dysfunction. Am J Geriatr Psychiatry. 2007;15:50-59.

[35] M. Ersek, M.M. Cherrier, S.S. Overman, et al. The cognitive effects of opioids. Pain Manag Nurs. 2004;5:75-93.

[36] L. Rasmussen, J. Stygall, S.P. Newman. Cognitive dysfunction and other long-term complications of surgery and anesthesia. In: R.D. Miller, editor. Miller’s anesthesia. 7th edition. Philadelphia: Churchill Livingstone/Elsevier; 2009:2v. xxii, 3084, I–89

[37] National Center for Health Statistics (U.S.). Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville (MD): Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2010.

[38] K.E. Fleischmann, L. Goldman, B. Young, et al. Association between cardiac and noncardiac complications in patients undergoing noncardiac surgery: outcomes and effects on length of stay. Am J Med. 2003;115:515-520.

[39] D. Rohan, D.J. Buggy, S. Crowley, et al. Increased incidence of postoperative cognitive dysfunction 24 hr after minor surgery in the elderly. Can J Anaesth. 2005;52:137-142.

[40] J.L. Rudolph, E.R. Marcantonio, D.J. Culley, et al. Delirium is associated with early postoperative cognitive dysfunction. Anaesthesia. 2008;63:941-947.

[41] L.M. Borowicz, M.A. Goldsborough, O.A. Selnes, et al. Neuropsychologic change after cardiac surgery: a critical review. J Cardiothorac Vasc Anesth. 1996;10:105-111. [quiz:111–2]

[42] D.P. Lowery, K. Wesnes, N. Brewster, et al. Subtle deficits of attention after surgery: quantifying indicators of sub syndrome delirium. Int J Geriatr Psychiatry. 2010;25:945-952.

[43] D.L. McDonagh, J.P. Mathew, W.D. White, et al. Cognitive function after major noncardiac surgery, apolipoprotein E4 genotype, and biomarkers of brain injury. Anesthesiology. 2010;112:852-859.

[44] K. Yaffe, J. Cauley, L. Sands, et al. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women. Arch Neurol. 1997;54:1110-1114.

[45] A. Slooter, M.-X. Tang, C. van Duign, et al. Apolipoprotein E e4 and the risk of dementia with stroke. A population-based investigation. JAMA. 1997;277:818-821.

[46] A. Henderson, S. Easteal, A. Jorm, et al. Apolipoprotein E allele e4, dementia, and cognitive decline in a population sample. Lancet. 1995;346:1387-1390.

[47] G. Maestre, R. Ottman, Y. Stern, et al. Apolipoprotein E and Alzheimer’s disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37:254-259.

[48] T.D. Bird. Genetic factors in Alzheimer’s disease. N Engl J Med. 2005;352:862-864.

[49] M. Dik, C. Jonker, L. Bouter, et al. APOE-e4 is associated with memory decline in cognitively impaired elderly. Neurology. 2000;54:1429-1497.

[50] C. Lahoz, E. Schaefer, L. Cupples, et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis. 2001;154:529-537.

[51] J. Davignon, R. Gregg, C. Sing. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.

[52] J. Stengard, K. Zebra, J. Pekkanen, et al. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 1995;91:265-269.

[53] R. Mahley, S. Rall. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: C. Scriver, A. Beaudet, W. Sly, et al, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill; 2001:2835-2862.

[54] J. Poirier, M. Hess, P. May, et al. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res. 1991;11:97-106.

[55] J. Boyle, C. Zoellner, L. Anderson. A role for apolipoprotein E, apolipoprotein A-1, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of rat sciatic nerve. J Clin Invest. 1989;83:1015-1031.

[56] A. LeBlanc, J. Poduslo. Regulation of apolipoprotein E gene expression after injury of the rat sciatic nerve. J Neurosci Res. 1990;25:162-171.

[57] R. Mahley. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;1988:622-630.

[58] B.E. Tardiff, M.F. Newman, A.M. Saunders, et al. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg. 1997;64:715-720.

[59] E.J. Heyer, D.A. Wilson, D.H. Sahlein, et al. APOE-epsilon4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy. Neurology. 2005;65:1759-1763.

[60] R.G. Lelis, J.E. Krieger, A.C. Pereira, et al. Apolipoprotein E4 genotype increases the risk of postoperative cognitive dysfunction in patients undergoing coronary artery bypass graft surgery. J Cardiovasc Surg (Torino). 2006;47:451-456.

[61] H. Abildstrom, M. Christiansen, V.D. Siersma, et al. Apolipoprotein E genotype and cognitive dysfunction after noncardiac surgery. Anesthesiology. 2004;101:855-861.

[62] J. Leung, L. Sands, Y. Wang, et al. Apolipoprotein E e4 allele increases the risk of early postoperative delirium in older patients undergoing noncardiac surgery. Anesthesiology. 2007;107:406-411.

[63] E.W. Ely, T.D. Girard, A.K. Shintani, et al. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med. 2007;35:112-117.

[64] M.S. Parihar, T. Hemnani. Alzheimer’s disease pathogenesis and therapeutic interventions. J Clin Neurosci. 2004;11:456-467.

[65] D.W. Tsuang, T.D. Bird. Genetics of dementia. Med Clin North Am. 2002;86:591-614.

[66] E.W. Moretti, R.W. Morris, M. Podgoreanu, et al. APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit Care Med. 2005;33:2521-2526.

[67] M.F. Newman, J.P. Mathew, H.P. Grocott, et al. Central nervous system injury associated with cardiac surgery. Lancet. 2006;368:694-703.

[68] O.A. Selnes, M.A. Goldsborough, L.M. Borowicz, et al. Neurobehavioural sequelae of cardiopulmonary bypass. Lancet. 1999;353:1601-1606.

[69] W. Pugsley, L. Klinger, C. Paschalis, et al. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke. 1994;25:1393-1399.

[70] J.P. Mathew, S.K. Shernan, W.D. White, et al. Preliminary report of the effects of complement suppression with pexelizumab on neurocognitive decline after coronary artery bypass graft surgery. Stroke. 2004;35:2335-2339.

[71] J. Jensen, L. Hedin, C. Widell, et al. Characteristics of heart failure in the elderly—a hospital cohort registry-based study. Int J Cardiol. 2008;125:191-196.

[72] Y.H. Liu, D.X. Wang, L.H. Li, et al. The effects of cardiopulmonary bypass on the number of cerebral microemboli and the incidence of cognitive dysfunction after coronary artery bypass graft surgery. Anesth Analg. 2009;109:1013-1022.

[73] D.J. Culley, Z. Xie, G. Crosby. General anesthetic-induced neurotoxicity: an emerging problem for the young and old? Curr Opin Anaesthesiol. 2007;20:408-413.

[74] A. Hole, T. Terjesen, H. Brevik. Epidural versus general anaesthesia for total hip arthroplasty in elderly patients. Acta Anaesthesiol Scand. 1980;24:279-287.

[75] D. Berggren, Y. Gustafson, B. Eriksson, et al. Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg. 1987;66:497-504.

[76] D. O’Hara, A. Duff, J. Berlin, et al. The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology. 2000;92:947-957.

[77] P. Williams-Russo, N. Sharrock, S. Mattis, et al. Randomized trial of hypotensive epidural anesthesia in older adults. Anesthesiology. 1999;91:926-935.

[78] M. Cibelli, A. Fidalgo, N. Terrando, et al. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol. 2010;68:360-368.

[79] P. Kobbe, Y. Vodovotz, D.J. Kaczorowski, et al. Patterns of cytokine release and evolution of remote organ dysfunction after bilateral femur fracture. Shock. 2008;30:43-47.

[80] J.J. Wang. Group reminiscence therapy for cognitive and affective function of demented elderly in Taiwan. Int J Geriatr Psychiatry. 2007;22:1235-1240.

[81] H.A. Rosczyk, N.L. Sparkman, R.W. Johnson. Neuroinflammation and cognitive function in aged mice following minor surgery. Exp Gerontol. 2008;43:840-846.

[82] N. Terrando, A. Rei Fidalgo, M.P. Vizcaychipi, et al. The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction. Crit Care. 2010;14:R88.

[83] Y. Stern. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc. 2002;8:448-460.

[84] D.A. Evans, L.A. Beckett, T.S. Field, et al. Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. JAMA. 1997;277:822-824.

[85] M. Zhang. [Prevalence study on dementia and Alzheimer disease]. Zhonghua Yi Xue Za Zhi. 1990;70:424-428. 30 [in Chinese]

[86] L. Letenneur, D. Commenges, J.F. Dartigues, et al. Incidence of dementia and Alzheimer’s disease in elderly community residents of south-western France. Int J Epidemiol. 1994;23:1256-1261.

[87] M.J. Valenzuela, P. Sachdev. Brain reserve and cognitive decline: a non-parametric systematic review. Psychol Med. 2006;36:1065-1073.

[88] J.B. Dijkstra, M.P. Van Boxtel, P.J. Houx, et al. An operation under general anesthesia as a risk factor for age-related cognitive decline: results from a large cross-sectional population study. J Am Geriatr Soc. 1998;46:1258-1265.

[89] H. Abildstrom, L.S. Rasmussen, P. Rentowl, et al. Cognitive dysfunction 1–2 years after non-cardiac surgery in the elderly. ISPOCD group. International Study of Post-Operative Cognitive Dysfunction. Acta Anaesthesiol Scand. 2000;44:1246-1251.

[90] N. Billig, P. Stockton, J. Cohen-Mansfield. Cognitive and affective changes after cataract surgery in an elderly population. Am J Geriatr Psychiatry. 1996;4:29-38.

[91] H. Gilberstadt, R. Aberwald, S. Crosbie, et al. Effect of surgery on psychological and social functioning in elderly patients. Arch Intern Med. 1968;122:109-115.

[92] P. Stockton, J. Cohen-Mansfield, N. Billig. Mental status change in older surgical patients. Cognition, depression, and other comorbidity. Am J Geriatr Psychiatry. 2000;8:40-46.

[93] M.Z. Goldstein, B.S. Fogel, B.L. Young. Effect of elective surgery under general anesthesia on mental status variables in elderly women and men: 10-month follow-up. Int Psychogeriatr. 1996;8:135-149.

[94] M.F. Newman, J.L. Kirchner, B. Phillips-Bute, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395-402.

[95] M. Avidan, A. Searleman, M. Storandt, et al. Long-term cognitive decline in elderly people was not attributable to non-cardiac surgery or major illness. Anesthesiology. 2009;111:964-970.

[96] M.L. Ancelin, G. de Roquefeuil, B. Ledesert, et al. Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly. Br J Psychiatry. 2001;178:360-366.

[97] J Leung, L Sands, E Mullen, et al. Are preoperative depressive symptoms associated with postoperative delirium in geriatric surgical patients? J Gerontol A Biol Sci Med Sci. 2005;60:1563-1568.

[98] J.M. Leung, L.P. Sands, L.E. Vaurio, et al. Nitrous oxide does not change the incidence of postoperative delirium or cognitive decline in elderly surgical patients. Br J Anaesth. 2006;96:754-760.

[99] J.M. Leung, L.P. Sands, S. Paul, et al. Does postoperative delirium limit the use of patient-controlled analgesia in older surgical patients? Anesthesiology. 2009;111:625-631.

[100] L. Vaurio, L. Sands, Y. Wang, et al. The role of pain and medications on postoperative delirium. Anesth Analg. 2006;102:267-273.

Supported in part by National Institutes of Health grant 1RO1AG031795-02.